173 related articles for article (PubMed ID: 31876833)
1. 18F-FDG Uptake of Localized Malignant Peritoneal Mesothelioma.
Kodama E; Kodama T; Ichikawa T; Ikoma H; Hashimoto J
Clin Nucl Med; 2020 Feb; 45(2):161-163. PubMed ID: 31876833
[TBL] [Abstract][Full Text] [Related]
2. A Case of Localized Malignant Peritoneal Mesothelioma With Lung Cancer Detected by 18F-FDG PET/CT.
Kobayashi Shimizu S; Okamura T; Koyama K; Seura H; Nishida N
Clin Nucl Med; 2020 Oct; 45(10):795-797. PubMed ID: 32558713
[TBL] [Abstract][Full Text] [Related]
3. A Case of Localized Malignant Peritoneal Mesothelioma Evaluated by 18F-FDG PET/CT.
Xu T; Hu J; Zhang X; Cao J; Chen Y
Clin Nucl Med; 2020 Nov; 45(11):890-891. PubMed ID: 32604114
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Domènech-Vilardell A; Rasiej MJ; Taub RN; Ichise M
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):54-61. PubMed ID: 24727854
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.
Dubreuil J; Giammarile F; Rousset P; Rubello D; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A
Nucl Med Commun; 2017 Apr; 38(4):312-318. PubMed ID: 28244976
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
Lim JH; Choi JY; Im Y; Yoo H; Jhun BW; Jeong BH; Park HY; Lee K; Kim H; Kwon OJ; Han J; Ahn MJ; Kim J; Um SW
PLoS One; 2020; 15(2):e0229299. PubMed ID: 32069313
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT Revealing Constrictive Pericarditis as the Only Manifestation of Malignant Mesothelioma.
Edel JP; Balink H
Clin Nucl Med; 2019 Jan; 44(1):55-56. PubMed ID: 30371590
[TBL] [Abstract][Full Text] [Related]
9. Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report.
Miyata T; Fujiwara Y; Nishijima K; Futagami F; Nakamura T; Takamura H
J Med Case Rep; 2019 Mar; 13(1):66. PubMed ID: 30879467
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results.
Lococo F; Rena O; Torricelli F; Filice A; Rapicetta C; Boldorini R; Paci M; Versari A
Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):593-596. PubMed ID: 32003806
[TBL] [Abstract][Full Text] [Related]
11. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
Kanemura S; Kuribayashi K; Funaguchi N; Shibata E; Mikami K; Doi H; Kitajima K; Hasegawa S; Nakano T
Eur J Radiol; 2017 Jan; 86():92-98. PubMed ID: 28027772
[TBL] [Abstract][Full Text] [Related]
12. Computed Tomographic Features of Malignant Peritoneal Mesothelioma.
Kato K; Gemba K; Fujimoto N; Aoe K; Takeshima Y; Inai K; Kishimoto T
Anticancer Res; 2016 Mar; 36(3):1067-72. PubMed ID: 26976999
[TBL] [Abstract][Full Text] [Related]
13. Primary malignant peritoneal mesothelioma: appearance on F-18 FDG positron emission tomographic images.
Eade TN; Fulham MJ; Constable CJ
Clin Nucl Med; 2002 Dec; 27(12):924-5. PubMed ID: 12607890
[No Abstract] [Full Text] [Related]
14. Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Le BB; Nguyen BD
Clin Nucl Med; 2015 Jan; 40(1):e68-70. PubMed ID: 24830875
[TBL] [Abstract][Full Text] [Related]
15. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
16. FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.
Incerti E; Broggi S; Fodor A; Cuzzocrea M; Samanes Gajate AM; Mapelli P; Fiorino C; Dell'Oca I; Pasetti M; Cattaneo M; Calandrino R; Gianolli L; Di Muzio N; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2071-2078. PubMed ID: 29876617
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pretreatment volume-based quantitative
Kitajima K; Doi H; Kuribayashi K; Hashimoto M; Tsuchitani T; Tanooka M; Fukushima K; Nakano T; Hasegawa S; Hirota S
Eur J Radiol; 2017 Jan; 86():176-183. PubMed ID: 28027744
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
Dubreuil J; Giammarile F; Rousset P; Rubello D; Colletti PM; Glehen O; Skanjeti A
Nucl Med Commun; 2017 Jan; 38(1):1-9. PubMed ID: 27820721
[TBL] [Abstract][Full Text] [Related]
19.
Niccoli Asabella A; Di Palo A; Altini C; Fanelli M; Ferrari C; Lavelli V; Ranieri G; Gadaleta CD; Rubini G
Hell J Nucl Med; 2018; 21(3):191-197. PubMed ID: 30411729
[TBL] [Abstract][Full Text] [Related]
20. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
